Healthcare & Life Sciences
CatalYm
United Statescatalym.com
CatalYm is a series c plus startup based in Germany. 2 investors tracked.
Activeseries-c-plus
series-c-plus
Stage
2023
Founded
3
Investors
About CatalYm
CatalYm is a startup founded in 2023 based in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 3 investors associated with the company.
CatalYm develops immune therapies targeting GDF-15 to overcome resistance mechanisms in cancer treatment and to treat cancer cachexia.
Explore CatalYm's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.